HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

P Giannessi Selected Research

Breast Neoplasms (Breast Cancer)

7/2004Multicenter randomized phase III trial of epirubicin plus paclitaxel vs epirubicin followed by paclitaxel in metastatic breast cancer patients: focus on cardiac safety.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


P Giannessi Research Topics

Disease

1Breast Neoplasms (Breast Cancer)
07/2004
1Heart Failure
07/2004
1Cardiotoxicity
07/2004

Drug/Important Bio-Agent (IBA)

1Epirubicin (Ellence)FDA LinkGeneric
07/2004
1Paclitaxel (Taxol)FDA LinkGeneric
07/2004